Clinical trial
A Phase II Randomized, Placebo-Controlled, Double Blinded, Multi-Centre Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis
NCT03272503 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized, Placebo-Controlled, Double Blinded, Multi-Centre Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis
- Lead sponsor
- University of Calgary
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 27, 2017
- Completion date
- December 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.